Korea Q1 Roundup: Overseas Sales, COVID Prove Positive In Mixed Results

SK Bioscience Files For Vaccine

earnings season
SK Bioscience, SK Biopharm Unveil Ambitious Growth Strategies • Source: Shutterstock

More from South Korea

More from Focus On Asia